Send to:

Choose Destination
See comment in PubMed Commons below
J Rheumatol Suppl. 2012 Jul;89:32-5. doi: 10.3899/jrheum.120239.

Mortality and causes of death in psoriatic arthritis.

Author information

  • 1Rheumatology Department, Royal National Hospital for Rheumatic Diseases, Bath, UK.



To evaluate the mortality associated with psoriatic arthritis (PsA) and causes of death.


Data were evaluated from several published studies identified by a literature search. A standardized mortality ratio was documented when available, as were causes of death derived from clinical databases, death certificates, and mortality databases. In some studies, mortality data was stratified by sex, age, and calendar year with time trend analysis.


There were variable reports of increased mortality in PsA that may be explained by factors such as pattern of referral, the severity of arthritis and/or skin psoriasis, and treatment exposure. There appears to be a greater incidence of cardiovascular death in psoriatic disease, although further studies are needed to separate the effect of skin psoriasis from arthritis.


PsA is not a mild disease and mortality may be increased in more severe disease. Although cardiovascular risk is more substantiated in severe psoriasis than in arthritis, it would be remiss not to evaluate the cardiovascular risk profile in all patients with psoriatic disease. It is important to treat patients with PsA early and aggressively to prevent disease severity that may influence longevity.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk